We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+0.46%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25B
AUM Growth
+$717M
(+3%)
Cap. Flow
+$287M
Cap. Flow
% of AUM
1.15%
Top 10 Holdings %
Top 10 Hldgs %
15.42%
Holding
1,535
New
112
Increased
562
Reduced
493
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$247M |
| 2 |
IBM
IBM
|
+$171M |
| 3 |
AutoZone
AZO
|
+$137M |
| 4 |
Moody's
MCO
|
+$124M |
| 5 |
Bank of America
BAC
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$162M |
| 2 |
AET
Aetna Inc
AET
|
+$149M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$137M |
| 4 |
Travelers Companies
TRV
|
+$130M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.59% |
| 2 | Financials | 13.97% |
| 3 | Technology | 12.86% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Alnylam Pharmaceuticals
ALNY
$31.9B
| $8.2M | 0.03% |
68,367
| – | – |
|
452
Conagra Brands
CAG
$7.21B
| $8.18M | 0.03% |
240,552
-3,345,189
| -93% | -$100M |
|
453
Marvell Technology
MRVL
$199B
| $8.07M | 0.03% |
612,070
-2,029,900
| -77% | -$29.1M |
|
|
SCHW
454
Charles Schwab
SCHW
$186B
| $8.03M | 0.03% |
245,928
-29,974
| -11% | -$947K |
|
455
Agios Pharmaceuticals
AGIO
$1.96B
| $7.96M | 0.03% |
71,664
| – | – |
|
|
PRXL
456
DELISTED
Parexel International Corp
PRXL
| $7.96M | 0.03% |
123,722
+7,822
| +7% | +$527K |
|
457
Church & Dwight Co
CHD
$22.4B
| $7.87M | 0.03% |
194,088
+70,026
| +56% | +$2.93M |
|
458
New Oriental
EDU
$8.95B
| $7.87M | 0.03% |
320,943
-111,238
| -26% | -$2.76M |
|
459
Global Payments
GPN
$23.5B
| $7.77M | 0.03% |
150,198
-15,062
| -9% | -$772K |
|
|
COL
460
DELISTED
Rockwell Collins
COL
| $7.75M | 0.03% |
83,900
+22,800
| +37% | +$2.19M |
|
461
Dollar General
DG
$27.5B
| $7.59M | 0.03% |
97,700
+58,100
| +147% | +$4.38M |
|
462
Ambev
ABEV
$46.6B
| $7.59M | 0.03% |
1,243,893
+852,824
| +218% | +$5.27M |
|
463
M&T Bank
MTB
$34B
| $7.53M | 0.03% |
60,300
+9,400
| +18% | +$1.16M |
|
464
iShares Russell Mid-Cap Growth ETF
IWP
$19B
| $7.53M | 0.03% |
155,508
| – | – |
|
|
NUVA
465
DELISTED
NuVasive, Inc.
NUVA
| $7.5M | 0.03% |
158,366
+1,700
| +1% | +$79.5K |
|
466
iShares China Large-Cap ETF
FXI
$4.1B
| $7.49M | 0.03% |
162,550
+6,700
| +4% | +$332K |
|
467
APA Corp
APA
$16.6B
| $7.39M | 0.03% |
128,167
+9,478
| +8% | +$597K |
|
468
Estee Lauder
EL
$34.8B
| $7.29M | 0.03% |
84,097
-81,361
| -49% | -$7.02M |
|
|
TEN
469
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $7.28M | 0.03% |
126,797
+30,610
| +32% | +$1.8M |
|
470
PG&E
PCG
$29B
| $7.28M | 0.03% |
148,300
-638,200
| -81% | -$33.2M |
|
|
GNCA
471
DELISTED
Genocea Biosciences, Inc.
GNCA
| $7.28M | 0.03% |
66,297
| – | – |
|
|
NVDQ
472
DELISTED
Novadaq Technologies Inc.
NVDQ
| $7.24M | 0.03% |
598,000
-4,000
| -0.7% | -$47.8K |
|
473
Lam Research
LRCX
$339B
| $7.23M | 0.03% |
889,000
-5,095,560
| -85% | -$40M |
|
474
Brown-Forman Class B
BF.B
$12B
| $7.19M | 0.03% |
224,375
+103,437
| +86% | +$3.14M |
|
475
Bath & Body Works
BBWI
$3.37B
| $7.17M | 0.03% |
103,381
+51,830
| +101% | +$3.72M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2015 Portfolio in Review
As of Q2 2015, Axa held 1,535 positions worth $25B, up 3% from $24.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Axa's Q2 2015 filing shows 112 new, 562 increased, 493 reduced and 141 closed positions. Its largest new stake was Cooper Companies: 532,000 shares worth $23.7M. The largest sale was Oracle, an estimated $162M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Technology.
- Axa's largest Q2 2015 buy was Cooper Companies: 532,000 shares worth $23.7M.
- Axa added most to Deutsche Bank in Q2 2015, an estimated $247M increase.
- Axa's biggest Q2 2015 reduction was Oracle, cutting an estimated $162M.
- Axa fully exited Principal Financial Group in Q2 2015, selling an estimated $23.2M.
- Axa's ten largest holdings make up 15% of its $25B portfolio in Q2 2015.
- Axa opened 112 new positions and closed 141 in Q2 2015.
- Axa's portfolio value rose 3% quarter-over-quarter to $25B.
Based on Axa's 13F filing for Q2 2015, filed 13 Aug 2015.